280 related articles for article (PubMed ID: 26807321)
21. Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.
Diao X; Chen X; Pi Y; Zhang Y; Wang F; Liu P; Gao Y; Wang X; Yang S; Lu S
Oncol Rep; 2018 Aug; 40(2):1174-1184. PubMed ID: 29917167
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.
Cheng Y; Yu P; Duan X; Liu C; Xu S; Chen Y; Tan Y; Qiang Y; Shen J; Tao Z
Exp Ther Med; 2015 Jun; 9(6):2319-2324. PubMed ID: 26136980
[TBL] [Abstract][Full Text] [Related]
23. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
Ishikura N; Kawata H; Nishimoto A; Nakamura R; Tsunenari T; Watanabe M; Tachibana K; Shiraishi T; Yoshino H; Honma A; Emura T; Ohta M; Nakagawa T; Houjo T; Corey E; Vessella RL; Aoki Y; Sato H
Int J Oncol; 2015 Apr; 46(4):1560-72. PubMed ID: 25634071
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
25. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
[TBL] [Abstract][Full Text] [Related]
26. An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells.
Azeem W; Hellem MR; Olsen JR; Hua Y; Marvyin K; Qu Y; Lin B; Ke X; Øyan AM; Kalland KH
PLoS One; 2017; 12(6):e0177861. PubMed ID: 28570625
[TBL] [Abstract][Full Text] [Related]
27. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-4 in patients with prostate cancer.
Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T
Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of clusterin and its isoforms by androgens in prostate cells.
Cochrane DR; Wang Z; Muramaki M; Gleave ME; Nelson CC
J Biol Chem; 2007 Jan; 282(4):2278-87. PubMed ID: 17148459
[TBL] [Abstract][Full Text] [Related]
30. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
[TBL] [Abstract][Full Text] [Related]
31. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
32. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.
Cheng H; Snoek R; Ghaidi F; Cox ME; Rennie PS
Cancer Res; 2006 Nov; 66(21):10613-20. PubMed ID: 17079486
[TBL] [Abstract][Full Text] [Related]
33. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
35. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
36. A novel transcriptional network for the androgen receptor in human epididymis epithelial cells.
Yang R; Browne JA; Eggener SE; Leir SH; Harris A
Mol Hum Reprod; 2018 Sep; 24(9):433-443. PubMed ID: 30016502
[TBL] [Abstract][Full Text] [Related]
37. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis.
Takayama K; Kaneshiro K; Tsutsumi S; Horie-Inoue K; Ikeda K; Urano T; Ijichi N; Ouchi Y; Shirahige K; Aburatani H; Inoue S
Oncogene; 2007 Jun; 26(30):4453-63. PubMed ID: 17297473
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types.
Blok LJ; Themmen AP; Peters AH; Trapman J; Baarends WM; Hoogerbrugge JW; Grootegoed JA
Mol Cell Endocrinol; 1992 Oct; 88(1-3):153-64. PubMed ID: 1334008
[TBL] [Abstract][Full Text] [Related]
40. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
Koirala S; Thomas LN; Too CK
Mol Endocrinol; 2014 Mar; 28(3):331-43. PubMed ID: 24433040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
